Zydus Lifesciences Ltd.

United States Food and Drug Administration (USFDA) has conducted an inspection at the Zydus group’s formulation manufacturing plant located SEZ -- II, Ahmedabad. The inspection was a Pre-Approval Inspection (PAI) for 3 products with general cGMP and was conducted from August 11 to August 13, 2025. The inspection concluded with NIL observations.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.